human | Q5 |
P11496 | CiNii Research ID | 1420282801190687104 |
P9776 | e-Rad researcher number | 80456897 |
P7783 | J-GLOBAL ID | 201401093071290618 |
P3835 | Mendeley person ID | yukinori-matsuo |
P496 | ORCID iD | 0000-0002-4372-8259 |
P3829 | Publons author ID | 533972 |
P1053 | ResearcherID | O-6200-2014 |
P5029 | Researchmap ID | MatsuoY |
P1153 | Scopus author ID | 9239837700 |
P69 | educated at | Kyoto University | Q336264 |
P108 | employer | Kyoto University | Q336264 |
Kindai University | Q912329 | ||
P734 | family name | Matsuo | Q24090443 |
Matsuo | Q24090443 | ||
Matsuo | Q24090443 | ||
P735 | given name | Yukinori | Q8060732 |
Yukinori | Q8060732 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q88554784 | A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence |
Q58757348 | A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer |
Q48668589 | A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy |
Q55114654 | A promising result of locoregional tumor control with biologically adaptive radiotherapy in patients with locally advanced non-small cell lung cancer. |
Q61446067 | A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy |
Q53652716 | Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy. |
Q38721317 | Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study |
Q48664378 | Baseline correction of a correlation model for improving the prediction accuracy of infrared marker-based dynamic tumor tracking |
Q57150774 | Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer |
Q37739617 | Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer |
Q64325948 | Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database |
Q45157055 | Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame |
Q51476255 | Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer. |
Q85676396 | Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis |
Q92521387 | Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients |
Q36767669 | Current status of stereotactic body radiotherapy for lung cancer |
Q39702333 | Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol |
Q36210612 | Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT. |
Q36285058 | Development of a four-dimensional Monte Carlo dose calculation system for real-time tumor-tracking irradiation with a gimbaled X-ray head |
Q34514441 | Differences in dose-volumetric data between the analytical anisotropic algorithm and the x-ray voxel Monte Carlo algorithm in stereotactic body radiation therapy for lung cancer |
Q36661346 | Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer |
Q38801355 | Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer |
Q53178520 | Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. |
Q44406043 | Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer |
Q39395497 | Dosimetric comparison of lung stereotactic body radiotherapy treatment plans using averaged computed tomography and end-exhalation computed tomography images: Evaluation of the effect of different dose-calculation algorithms and prescription methods |
Q50875685 | Dosimetric evaluation of the Acuros XB algorithm for a 4 MV photon beam in head and neck intensity-modulated radiation therapy. |
Q42321832 | Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors |
Q43804177 | Dosimetric impact of gold markers implanted closely to lung tumors: a Monte Carlo simulation |
Q83190161 | Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer |
Q48652169 | Dynamic tumor-tracking radiotherapy with real-time monitoring for liver tumors using a gimbal mounted linac |
Q99239159 | Dynamic tumor-tracking stereotactic body radiation therapy for a solitary tumor in a transplanted organ: two case reports |
Q51794979 | Effect of audio coaching on correlation of abdominal displacement with lung tumor motion. |
Q51164177 | Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method. |
Q51286974 | Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer. |
Q59335153 | Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer |
Q47356300 | Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy. |
Q50610138 | Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac. |
Q53459469 | Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. |
Q38842046 | Evaluation of the prevalence of burnout and psychological morbidity among radiation oncologist members of the Kyoto Radiation Oncology Study Group (KROSG). |
Q51578417 | Experimental validation of heterogeneity-corrected dose-volume prescription on respiratory-averaged CT images in stereotactic body radiotherapy for moving tumors. |
Q57058757 | Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702) |
Q53391674 | Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. |
Q36833711 | Guidelines for respiratory motion management in radiation therapy |
Q84880388 | Hyperfractionated irradiation with 3 cycles of induction chemotherapy in stage IIIA-N2 lung cancer |
Q91018881 | Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer |
Q88740973 | Impact of low skeletal muscle mass on non-lung cancer mortality after stereotactic body radiotherapy for patients with stage I non-small cell lung cancer |
Q43515856 | Impact of motion velocity on four-dimensional target volumes: a phantom study |
Q38265753 | Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer |
Q36373998 | Impact of sampling interval in training data acquisition on intrafractional predictive accuracy of indirect dynamic tumor-tracking radiotherapy. |
Q48533010 | Influence of the correlation modeling period on the prediction accuracy of infrared marker-based dynamic tumor tracking using a gimbaled X-ray head |
Q36851015 | Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc. |
Q85639610 | Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy |
Q45128988 | Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer |
Q43910024 | Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy |
Q83863655 | Interfractional reproducibility in pancreatic position based on four-dimensional computed tomography |
Q51919778 | Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. |
Q48886961 | Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers |
Q39207321 | Intrafractional tracking accuracy in infrared marker-based hybrid dynamic tumour-tracking irradiation with a gimballed linac. |
Q33645887 | Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients |
Q33438674 | Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma |
Q47174044 | Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer |
Q36843349 | Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study |
Q48621432 | Multivariate analysis for the estimation of target localization errors in fiducial marker-based radiotherapy |
Q45762954 | New algorithm to simulate organ movement and deformation for four-dimensional dose calculation based on a three-dimensional CT and fluoroscopy of the thorax |
Q48762839 | Optimization of the x-ray monitoring angle for creating a correlation model between internal and external respiratory signals |
Q52381358 | Optimization of training periods for the estimation model of three-dimensional target positions using an external respiratory surrogate. |
Q48202266 | Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). |
Q39087641 | Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc |
Q40669964 | Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702). |
Q82467952 | Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer |
Q49579195 | Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors |
Q37787415 | Positional Reproducibility of Pancreatic Tumors Under End-Exhalation Breath-Hold Conditions Using a Visual Feedback Technique |
Q53053644 | Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET. |
Q39355265 | Predictive uncertainty in infrared marker-based dynamic tumor tracking with Vero4DRT. |
Q54281644 | Preliminary Analysis of Pretreatment Diffusion-Weighted MRI and (18)F-FDG PET/CT as Prognostic Factors in Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy. |
Q83263602 | Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer |
Q35661919 | Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer |
Q47857798 | Prognostic Significance of Serum CEA for Non-small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy |
Q51565476 | Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. |
Q48504249 | Quantification of the kV X-ray imaging dose during real-time tumor tracking and from three- and four-dimensional cone-beam computed tomography in lung cancer patients using a Monte Carlo simulation |
Q45052957 | Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis |
Q43597863 | Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx |
Q38777891 | SU-E-J-142: Gafchromic Film Dosimetry in Fluoroscopy for Dynamic Tumor Tracking Irradiation of the Lung Using XR-SP2 Model - A Phantom Study. |
Q44555068 | Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation |
Q88149536 | Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy |
Q51742335 | Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. |
Q64081408 | Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer |
Q57764566 | Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study |
Q79421790 | Stereotactic body radiation therapy (SBRT) for early-stage lung cancer |
Q50697411 | Stereotactic body radiation therapy for lung cancer: achievements and perspectives. |
Q93064494 | Stereotactic body radiotherapy as an alternative to metastasectomy for pulmonary oligometastasis |
Q80976956 | Stereotactic body radiotherapy for oligometastatic lung tumors |
Q90087984 | Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses |
Q84524583 | Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group |
Q35591817 | Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma |
Q48661723 | Target localization errors from fiducial markers implanted around a lung tumor for dynamic tumor tracking |
Q39430055 | Technical Note: Introduction of variance component analysis to setup error analysis in radiotherapy |
Q51124161 | The accuracy of extracted target motion trajectories in four-dimensional cone-beam computed tomography for lung cancer patients. |
Q34366525 | The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer |
Q50802046 | Transurethral coil embolization for the management of ureteroarterial fistula: a case report. |
Q40596060 | Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer: Importance of Salvage Surgery. |
Q91896990 | Tumour volume comparison between 16-row multi-detector computed tomography and 320-row area-detector computed tomography in patients with small lung tumours treated with stereotactic body radiotherapy: Effect of respiratory motion |
Q47745150 | Use of a second-dose calculation algorithm to check dosimetric parameters for the dose distribution of a first-dose calculation algorithm for lung SBRT plans. |
Q45003519 | Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer |
Q83150533 | [Stereotactic body radiotherapy (SBRT)] |
Search more.